Selected article for: "clinical trial and design clinical trial"
Author: He, Jiayang; Li, Zhengtu; Huang, Wanyi; Guan, Wenda; Ma, Hongxia; Yang, Zi feng; Wang, Xinhua
Title: Efficacy and safety of Chou-Ling-Dan granules in the treatment of seasonal influenza via combining Western and traditional Chinese medicine: protocol for a multicentre, randomised controlled clinical trial
  • Document date: 2019_4_2
    • ID: vn9e5nm3_1
    Snippet: Methods and analysis The study is designed as a multi-centre, randomised, double-blinded, 30 double-simulation, oseltamivir-and placebo-controlled, parallel-design clinical trial. Eligible Increases evidence for the clinical use of CLD granules to treat seasonal influenza. 61 Take a robust 21-day patient follow-up. the study flowchart is shown in Fig. 1 ......
    Document: Methods and analysis The study is designed as a multi-centre, randomised, double-blinded, 30 double-simulation, oseltamivir-and placebo-controlled, parallel-design clinical trial. Eligible Increases evidence for the clinical use of CLD granules to treat seasonal influenza. 61 Take a robust 21-day patient follow-up. the study flowchart is shown in Fig. 1 .

    Search related documents:
    Co phrase search for related documents
    • analysis method and parallel design: 1, 2, 3
    • analysis method and placebo control: 1
    • analysis method and seasonal influenza: 1, 2, 3, 4
    • clinical trial and double simulation: 1, 2, 3
    • clinical trial and parallel design: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical trial and parallel design clinical trial: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical trial and placebo control: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical trial and seasonal influenza: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • double simulation and parallel design: 1, 2, 3
    • double simulation and parallel design clinical trial: 1, 2, 3
    • double simulation and seasonal influenza: 1
    • eligible increase and seasonal influenza: 1
    • parallel design and placebo control: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • parallel design and seasonal influenza: 1, 2
    • parallel design clinical trial and placebo control: 1, 2, 3, 4, 5, 6
    • parallel design clinical trial and seasonal influenza: 1, 2